Hypercrosslinked polymers (HCPs) are typically synthesised over 24-hour batch reactions, limiting productivity rates during scale-up production. Continuous flow synthesis can potentially overcome this limitation. However, the formation of insoluble HCP...
Polymer production in the 21stcentury will require alternative
approaches that do not impact the environment negatively. We recently
reported that the synthesis of hypercrosslinked polymers (HCPs) via continuous flow synthesis required less than 99% of
the time required in conventional batch reactions. However, the impact
of deploying flow synthesis of HCPs and their application on the environment
remain unknown. Here, we assessed the environmental impacts of HCP
synthesis via batch and flow reactions and their
application in water treatment through life-cycle assessment (LCA).
These impacts were represented as normalized scores in four end point
impact categories: Human health, Ecosystem quality, Climate change,
and Resources. Yielding the same amount of HCPs, flow synthesis demonstrated
lower end point impacts in all categories. This was due to consuming
only 5% of the electricity required for batch reactions. As the specific
surface areas of flow-produced HCPs were lower than those of batch-produced
HCPs, 36% more flow-produced HCPs were required to remove Rhodamine
B (RB) and Uniblue A (UA) dyes from water. Despite this limitation,
using flow-produced HCPs for water treatment still scored lower overall
negative environmental impacts when compared to batch-produced HCPs.
Outcomes from this work showed that flow synthesis could enhance the
sustainability of scale-up HCP production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.